ArticleJournal of Cancer2019

MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells.

Xiaoque Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.